Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 113

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Applications of iPSC-derived beta cells from patients with diabetes

Maxwell, Kristina G., Millman, Jeffrey R. · 2021 · Cell Reports Medicine

Abstract

Improved stem cell-derived pancreatic islet (SC-islet) differentiation protocols robustly generate insulin-secreting β cells from patient induced pluripotent stem cells (iPSCs). These advances are enabling in vitro disease modeling studies and the development of an autologous diabetes cell replacement therapy. SC-islet technology elucidates key features of human pancreas development and diabetes disease progression through the generation of pancreatic progenitors, endocrine progenitors, and β cells derived from diabetic and nondiabetic iPSCs. Combining disease modeling with gene editing and next-generation sequencing reveals the impact of diabetes-causing mutations and diabetic phenotypes on multiple islet cell types. In addition, the supply of SC-islets, containing β and other islet cell types, is unlimited, presenting an opportunity for personalized medicine and overcoming several disadvantages posed by donor islets. This review highlights relevant studies involving iPSC-β cells and progenitors, encompassing new conclusions involving cells from patients with diabetes and the therapeutic potential of iPSC-β cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xcrm.2021.100238

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 70

  1. Meloche, 2007, Transplantation for the treatment of type 1 diabetes, World J. Gastroenterol., 13, 6347, 10.3748/wjg.v13.i47.6347 · doi:10.3748/wjg.v13.i47.6347
  2. Kharroubi, 2015, Diabetes mellitus: the epidemic of the century, World J. Diabetes, 6, 850, 10.4239/wjd.v6.i6.850 · DOI · Paper page
  3. Schwartz, 2017, A unified pathophysiological construct of diabetes and its complications, Trends Endocrinol. Metab., 28, 645, 10.1016/j.tem.2017.05.005 · DOI
  4. D’Amour, 2006, Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells, Nat. Biotechnol., 24, 1392, 10.1038/nbt1259 · DOI · Paper page
  5. D’Amour, 2005, Efficient differentiation of human embryonic stem cells to definitive endoderm, Nat. Biotechnol., 23, 1534, 10.1038/nbt1163 · DOI · Paper page
  6. Balboa, 2018, Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes, eLife, 7, e38519, 10.7554/eLife.38519 · DOI
  7. Ma, 2018, β cell replacement after gene editing of a neonatal diabetes-causing mutation at the insulin locus, Stem Cell Reports, 11, 1407, 10.1016/j.stemcr.2018.11.006 · DOI
  8. Tran, 2020, Developmentally-Inspired Biomimetic Culture Models to Produce Functional Islet-Like Cells From Pluripotent Precursors, Front. Bioeng. Biotechnol., 8, 583970, 10.3389/fbioe.2020.583970 · DOI
  9. Nostro, 2012, Generation of beta cells from human pluripotent stem cells: potential for regenerative medicine, Semin. Cell Dev. Biol., 23, 701, 10.1016/j.semcdb.2012.06.010 · DOI
  10. Velazco-Cruz, 2020, Advances Toward Engineering Functionally Mature Human Pluripotent Stem Cell-Derived β Cells, Front. Bioeng. Biotechnol., 8, 786, 10.3389/fbioe.2020.00786 · DOI
  11. Theis, 2019, A map of β-cell differentiation pathways supports cell therapies for diabetes, Nature, 569, 342, 10.1038/d41586-019-01211-9 · DOI
  12. Aguayo-Mazzucato, 2010, Stem cell therapy for type 1 diabetes mellitus, Nat. Rev. Endocrinol., 6, 139, 10.1038/nrendo.2009.274 · DOI · Paper page
  13. Tremmel, 2019, Mimicking nature-made beta cells: recent advances towards stem cell-derived islets, Curr. Opin. Organ Transplant., 24, 574, 10.1097/MOT.0000000000000687 · DOI
  14. Sui, 2018, β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells, Diabetes, 67, 26, 10.2337/db17-0120 · DOI
  15. Veres, 2019, Charting cellular identity during human in vitro β-cell differentiation, Nature, 569, 368, 10.1038/s41586-019-1168-5 · DOI · Paper page
  16. Cosentino, 2018, Pancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes, Nucleic Acids Res., 46, 10302, 10.1093/nar/gky839 · DOI
  17. Nostro, 2015, Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines, Stem Cell Reports, 4, 591, 10.1016/j.stemcr.2015.02.017 · DOI · Paper page
  18. Russ, 2015, Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro, EMBO J., 34, 1759, 10.15252/embj.201591058 · DOI · Paper page
  19. Kudva, 2012, Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes, Stem Cells Transl. Med., 1, 451, 10.5966/sctm.2011-0044 · DOI
  20. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  21. Leite, 2020, Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells, Cell Rep., 32, 107894, 10.1016/j.celrep.2020.107894 · DOI
  22. Wang, 2019, Point mutations in the PDX1 transactivation domain impair human β-cell development and function, Mol. Metab., 24, 80, 10.1016/j.molmet.2019.03.006 · DOI
  23. Dwivedi, 2019, Loss of ZnT8 function protects against diabetes by enhanced insulin secretion, Nat. Genet., 51, 1596, 10.1038/s41588-019-0513-9 · DOI
  24. Amin, 2018, Discovery of a drug candidate for GLIS3-associated diabetes, Nat. Commun., 9, 2681, 10.1038/s41467-018-04918-x · DOI
  25. Millman, 2016, Generation of stem cell-derived β-cells from patients with type 1 diabetes, Nat. Commun., 7, 11463, 10.1038/ncomms11463 · DOI · Paper page
  26. Thatava, 2013, Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells, Mol. Ther., 21, 228, 10.1038/mt.2012.245 · DOI
  27. Lithovius, 2021, SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism, Diabetologia, 64, 630, 10.1007/s00125-020-05346-7 · DOI
  28. Cardenas-Diaz, 2019, Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A, Cell Stem Cell, 25, 273, 10.1016/j.stem.2019.07.007 · DOI
  29. Kishore, 2020, A Non-Coding Disease Modifier of Pancreatic Agenesis Identified by Genetic Correction in a Patient-Derived iPSC Line, Cell Stem Cell, 27, 137, 10.1016/j.stem.2020.05.001 · DOI
  30. Stepniewski, 2015, Induced pluripotent stem cells as a model for diabetes investigation, Sci Rep, 5, 8597, 10.1038/srep08597 · DOI
  31. Shang, 2014, β-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome, Diabetes, 63, 923, 10.2337/db13-0717 · DOI · Paper page
  32. Teo, 2013, Derivation of Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young, J Biol Chem, 288, 5353, 10.1074/jbc.C112.428979 · DOI
  33. Steiner, 2010, Pancreatic islet plasticity: interspecies comparison of islet architecture and composition, Islets, 2, 135, 10.4161/isl.2.3.11815 · DOI · Paper page
  34. Eizirik, 1994, Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury, Proc. Natl. Acad. Sci. USA, 91, 9253, 10.1073/pnas.91.20.9253 · DOI · Paper page
  35. Simsek, 2016, Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells, Stem Cells Transl. Med., 5, 572, 10.5966/sctm.2015-0276 · DOI
  36. Harris, 2018, Monogenic diabetes: the impact of making the right diagnosis, Curr. Opin. Pediatr., 30, 558, 10.1097/MOP.0000000000000643 · DOI
  37. Augsornworawat, 2020, Single-cell RNA sequencing for engineering and studying human islets, Curr. Opin. Biomed. Eng., 16, 27, 10.1016/j.cobme.2020.06.003 · DOI
  38. Muraro, 2016, A single-cell transcriptome atlas of the human pancreas, Cell Syst., 3, 385, 10.1016/j.cels.2016.09.002 · DOI · Paper page
  39. Krentz, 2018, Single-Cell Transcriptome Profiling of Mouse and hESC-Derived Pancreatic Progenitors, Stem Cell Reports, 11, 1551, 10.1016/j.stemcr.2018.11.008 · DOI
  40. Hakonen, 2018, MANF protects human pancreatic beta cells against stress-induced cell death, Diabetologia, 61, 2202, 10.1007/s00125-018-4687-y · DOI
  41. Misun, 2020, In Vitro Platform for Studying Human Insulin Release Dynamics of Single Pancreatic Islet Microtissues at High Resolution, Adv. Biosyst., 4, e1900291, 10.1002/adbi.201900291 · DOI
  42. Lenguito, 2017, Resealable, optically accessible, PDMS-free fluidic platform for ex vivo interrogation of pancreatic islets, Lab Chip, 17, 772, 10.1039/C6LC01504B · DOI
  43. Jun, 2019, In vivo-mimicking microfluidic perfusion culture of pancreatic islet spheroids, Sci. Adv., 5, eaax4520, 10.1126/sciadv.aax4520 · DOI
  44. Sankar, 2011, Culturing pancreatic islets in microfluidic flow enhances morphology of the associated endothelial cells, PLoS ONE, 6, e24904, 10.1371/journal.pone.0024904 · DOI
  45. Glieberman, 2019, Synchronized stimulation and continuous insulin sensing in a microfluidic human islet on a chip designed for scalable manufacturing, Lab Chip, 19, 2993, 10.1039/C9LC00253G · DOI
  46. Ishahak, 2019, Integrated platform for operating and interrogating organs-on-chips, Anal. Methods, 11, 5645, 10.1039/C9AY01663E · DOI
  47. Wesolowska-Andersen, 2020, Analysis of Differentiation Protocols Defines a Common Pancreatic Progenitor Molecular Signature and Guides Refinement of Endocrine Differentiation, Stem Cell Reports, 14, 138, 10.1016/j.stemcr.2019.11.010 · DOI
  48. Li, 2020, Single-Cell RNA-Seq Reveals that CD9 Is a Negative Marker of Glucose-Responsive Pancreatic β-like Cells Derived from Human Pluripotent Stem Cells, Stem Cell Reports, 15, 1111, 10.1016/j.stemcr.2020.09.009 · DOI
  49. Zhu, 2017, PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration, Stem Cell Res. Ther., 8, 240, 10.1186/s13287-017-0694-z · DOI · Paper page
  50. Eichstadt, 2019, Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa, JCI Insight, 4, 130554, 10.1172/jci.insight.130554 · DOI
  51. Río, 2019, Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia, Nat. Med., 25, 1396, 10.1038/s41591-019-0550-z · DOI · Paper page
  52. Lee, 2020, Recent advances in genome editing of stem cells for drug discovery and therapeutic application, Pharmacol. Ther., 209, 107501, 10.1016/j.pharmthera.2020.107501 · DOI
  53. Sackett, 2017, The nexus of stem cell-derived beta-cells and genome engineering, Rev. Diabet. Stud., 14, 39, 10.1900/RDS.2017.14.39 · DOI
  54. Millman, 2017, Autologous Pluripotent Stem Cell-Derived β-Like Cells for Diabetes Cellular Therapy, Diabetes, 66, 1111, 10.2337/db16-1406 · DOI
  55. Stock, 2020, Conformal Coating of Stem Cell-Derived Islets for β Cell Replacement in Type 1 Diabetes, Stem Cell Reports, 14, 91, 10.1016/j.stemcr.2019.11.004 · DOI · Paper page
  56. Zhu, 2016, Human pancreatic beta-like cells converted from fibroblasts, Nat. Commun., 7, 10080, 10.1038/ncomms10080 · DOI
  57. Saber, 2018, Sex Differences in Maturation of Human Embryonic Stem Cell-Derived β Cells in Mice, Endocrinology, 159, 1827, 10.1210/en.2018-00048 · DOI
  58. Robert, 2018, Functional beta cell mass from device-encapsulated hESC-derived pancreatic endoderm achieving metabolic control, Stem Cell Reports, 10, 739, 10.1016/j.stemcr.2018.01.040 · DOI
  59. Chang, 2017, Nanoporous immunoprotective device for stem-cell-derived β-cell replacement therapy, ACS Nano, 11, 7747, 10.1021/acsnano.7b01239 · DOI
  60. Nathan, 1993, Long-term complications of diabetes mellitus, N. Engl. J. Med., 328, 1676, 10.1056/NEJM199306103282306 · DOI · Paper page
  61. Scharp, 1990, Insulin independence after islet transplantation into type I diabetic patient, Diabetes, 39, 515, 10.2337/diab.39.4.515 · DOI · Paper page
  62. Shapiro, 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen, N. Engl. J. Med., 343, 230, 10.1056/NEJM200007273430401 · DOI · Paper page
  63. Deuse, 2019, De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans, Nat. Biotechnol., 37, 1137, 10.1038/s41587-019-0227-7 · DOI
  64. de Rham, 2014, Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy, J. Immunol. Res., 2014, 518135
  65. Park, 2020, Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes, J. Transl. Med., 18, 236, 10.1186/s12967-020-02403-y · doi:10.1186/s12967-020-02403-y
  66. Turinetto, 2017, Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process, Int. J. Mol. Sci., 18, E1952, 10.3390/ijms18091952 · DOI
  67. Ng, 2020, A comprehensive library of human transcription factors for cell fate engineering, Nat. Biotechnol.
  68. Cardenas-Diaz, 2020, A Dual Reporter EndoC-βH1 Human β-Cell Line for Efficient Quantification of Calcium Flux and Insulin Secretion, Endocrinology, 161, bqaa005, 10.1210/endocr/bqaa005 · DOI
  69. Kracht, 2018, Bioluminescent reporter assay for monitoring ER stress in human beta cells, Sci. Rep., 8, 17738, 10.1038/s41598-018-36142-4 · DOI
  70. Burns, 2015, High-throughput luminescent reporter of insulin secretion for discovering regulators of pancreatic Beta-cell function, Cell Metab., 21, 126, 10.1016/j.cmet.2014.12.010 · DOI

Cited by

See all 113

Metadata

Authors
Maxwell, K. G., & Millman, J. R.
Venue
Cell Reports Medicine
Publisher
Elsevier BV
Published
2021-04
Volume
2
Issue
4
Pages
100238
ISSN
2666-3791
Cited by
113
References
24
Language
en
Licence
Funders
  • National Institutes of Health (R01DK114233, R01DK127497)
  • Juvenile Diabetes Research Foundation United States of America (5-CDA-2017-391-A-N)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Applications of iPSC-derived beta cells from patients with diabetes. https://app.cochat.ai/papers/10.1016/j.xcrm.2021.100238
The paper
Maxwell, K. G., & Millman, J. R. (2021). Applications of iPSC-derived beta cells from patients with diabetes. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2021.100238

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.